EFFECTS OF THE ANGIOTENSIN-II TYPE-1 RECEPTOR ANTAGONIST ZD7155 ON ANGIOTENSIN II-MEDIATED REGULATION OF RENIN SECRETION AND RENAL RENIN GENE-EXPRESSION, RENAL VASOCONSTRICTION, AND BLOOD-PRESSURE IN RATS
Bk. Kramer et al., EFFECTS OF THE ANGIOTENSIN-II TYPE-1 RECEPTOR ANTAGONIST ZD7155 ON ANGIOTENSIN II-MEDIATED REGULATION OF RENIN SECRETION AND RENAL RENIN GENE-EXPRESSION, RENAL VASOCONSTRICTION, AND BLOOD-PRESSURE IN RATS, Journal of cardiovascular pharmacology, 31(5), 1998, pp. 700-705
Angiotensin Ui receptors have recently been subclassified as type-1 or
type-2 receptors. The in vitro and in vivo effects of blocking the an
giotensin TI type-1 receptor with ZD7155, an angiotensin II type-1 sel
ective receptor antagonist, have been studied in angiotensin Ii-mediat
ed increases in cytosolic calcium in rat mesangial cells, in angiotens
in II-induced renal and systemic vasoconstriction, and in angiotensin
II-mediated regulation of renin secretion and renal renin gene express
ion. ZD7155 completely blocked the ability of angiotensin II to elicit
an increase in free intracellular calcium concentrations in rat mesan
gial cells. In isolated perfused rat kidneys, ZD7155 completely abolis
hed the angiotensin II-induced vasoconstriction and increased renin se
cretion to 700% of baseline levels. Furthermore. ZD7155 decreased syst
olic blood pressure by 16 mm Hg, increased plasma renin activity 3.7-f
old, and stimulated renal renin gene expression 4.2-fold in Sprague-Da
wley rats in vivo. Our results suggest that ZD7155 is a potent antagon
ist of the angiotensin II type-1 receptor, which mediates angiotensin
II-induced increases of free intracellular calcium concentrations in (
e.g., renal mesangial cells), constriction of the renal and systemic v
asculature, and inhibition of renin secretion and synthesis.